JP2018528948A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528948A5 JP2018528948A5 JP2018510724A JP2018510724A JP2018528948A5 JP 2018528948 A5 JP2018528948 A5 JP 2018528948A5 JP 2018510724 A JP2018510724 A JP 2018510724A JP 2018510724 A JP2018510724 A JP 2018510724A JP 2018528948 A5 JP2018528948 A5 JP 2018528948A5
- Authority
- JP
- Japan
- Prior art keywords
- apremilast
- toluene
- mixture
- acetic acid
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 9
- IMOZEMNVLZVGJZ-QGZVFWFLSA-N apremilast Chemical compound C1=C(OC)C(OCC)=CC([C@@H](CS(C)(=O)=O)N2C(C3=C(NC(C)=O)C=CC=C3C2=O)=O)=C1 IMOZEMNVLZVGJZ-QGZVFWFLSA-N 0.000 claims 4
- 229960001164 apremilast Drugs 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- BXUJVINGXQGNFD-SNVBAGLBSA-N (1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine Chemical compound CCOC1=CC([C@H](N)CS(C)(=O)=O)=CC=C1OC BXUJVINGXQGNFD-SNVBAGLBSA-N 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- PAUAJOABXCGLCN-UHFFFAOYSA-N n-(1,3-dioxo-2-benzofuran-4-yl)acetamide Chemical compound CC(=O)NC1=CC=CC2=C1C(=O)OC2=O PAUAJOABXCGLCN-UHFFFAOYSA-N 0.000 claims 1
- 230000000630 rising effect Effects 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211280P | 2015-08-28 | 2015-08-28 | |
| US62/211,280 | 2015-08-28 | ||
| US201662279147P | 2016-01-15 | 2016-01-15 | |
| US62/279,147 | 2016-01-15 | ||
| PCT/SG2016/050413 WO2017039537A1 (en) | 2015-08-28 | 2016-08-25 | Novel forms of apremilast and the process of making the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018528948A JP2018528948A (ja) | 2018-10-04 |
| JP2018528948A5 true JP2018528948A5 (enExample) | 2019-08-29 |
Family
ID=58097541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018510724A Pending JP2018528948A (ja) | 2015-08-28 | 2016-08-25 | アプレミラストの新規形態及びその作成方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9765026B2 (enExample) |
| EP (1) | EP3341360A4 (enExample) |
| JP (1) | JP2018528948A (enExample) |
| KR (1) | KR20180036791A (enExample) |
| CN (1) | CN107922332A (enExample) |
| CA (1) | CA2994217A1 (enExample) |
| IL (1) | IL257195A (enExample) |
| TW (1) | TWI613191B (enExample) |
| WO (1) | WO2017039537A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10370329B2 (en) * | 2015-04-27 | 2019-08-06 | Mylan Laboratories Limited | Process for the enantiomeric resolution of apremilast intermediates |
| WO2017033206A2 (en) * | 2015-08-27 | 2017-03-02 | Msn Laboratories Private Limited | Solid state forms of n-[2-[(1 s)-1 -(3-ethoxy-4-methoxyphenyl)-2-(methyl sulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-l h-isoindol-4-yl]acetamide and process for preparation thereof |
| CN106977444B (zh) * | 2016-01-18 | 2021-10-08 | 重庆医药工业研究院有限责任公司 | 一种阿普斯特无定型的制备方法 |
| EP3435973B1 (en) * | 2016-03-30 | 2023-11-01 | Sarudbhava Formulations Private Limited | Apremilast pharmaceutical compositions |
| CN107686461A (zh) * | 2016-08-04 | 2018-02-13 | 广东东阳光药业有限公司 | 阿普斯特的溶剂化物及其制备方法和用途 |
| WO2019021303A1 (en) * | 2017-07-23 | 2019-01-31 | Alkem Laboratories Limited | NOVEL PROCESS FOR THE PREPARATION OF APREMILAST IN AMORPHOUS FORM |
| CN108440381A (zh) * | 2018-03-15 | 2018-08-24 | 威海迪素制药有限公司 | 一种阿普斯特新晶型h及其制备方法 |
| TW202308995A (zh) | 2021-04-26 | 2023-03-01 | 美商安進公司 | 用於合成阿普斯特之方法 |
| WO2023120466A1 (ja) * | 2021-12-23 | 2023-06-29 | 沢井製薬株式会社 | アプレミラスト水和物含有製剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| JP2009513704A (ja) * | 2005-11-01 | 2009-04-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | グルコキナーゼのアロステリックモジュレーターとしての置換ジヒドロイソインドロン |
| CN102046167A (zh) | 2008-03-27 | 2011-05-04 | 细胞基因公司 | 包含(+)-2-[1-(3-乙氧基-4-甲氧基苯基)-2-甲基磺酰基乙基]-4-乙酰基氨基异吲哚啉-1,3-二酮的固体形式、其组合物及其用途 |
| CA2761845C (en) | 2009-05-14 | 2015-01-20 | Tianjin Hemay Bio-Tech Co., Ltd. | Thiophene[3,4-c]pyrrole pde4 mediators |
| EP2723717A2 (en) * | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| US8981117B2 (en) | 2012-09-14 | 2015-03-17 | Celgene Corporation | Processes for the preparation of isoindole compounds and isotopologues thereof |
| UY35103A (es) * | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
| EP2730278A1 (en) * | 2012-11-08 | 2014-05-14 | Ratiopharm GmbH | Composition melt |
| IN2014MU01283A (enExample) | 2014-04-04 | 2015-10-09 | Cadila Healthcare Ltd | |
| CN104447445B (zh) | 2014-12-05 | 2016-07-06 | 新发药业有限公司 | 一种合成阿普斯特中间体的制备方法 |
| MX2017015151A (es) | 2015-05-26 | 2018-08-15 | Lupin Ltd | Un proceso mejorado para la preparación de apremilast y novedosos polimorfos del mismo. |
| US20180334429A1 (en) * | 2015-06-09 | 2018-11-22 | Dr. Reddy's Laboratories Limited | Process for preparation of apremilast and its intermediates |
-
2016
- 2016-08-24 US US15/246,392 patent/US9765026B2/en active Active
- 2016-08-25 EP EP16842429.9A patent/EP3341360A4/en not_active Withdrawn
- 2016-08-25 JP JP2018510724A patent/JP2018528948A/ja active Pending
- 2016-08-25 CA CA2994217A patent/CA2994217A1/en not_active Abandoned
- 2016-08-25 CN CN201680050410.4A patent/CN107922332A/zh active Pending
- 2016-08-25 KR KR1020187008651A patent/KR20180036791A/ko not_active Ceased
- 2016-08-25 WO PCT/SG2016/050413 patent/WO2017039537A1/en not_active Ceased
- 2016-08-26 TW TW105127548A patent/TWI613191B/zh active
-
2018
- 2018-01-28 IL IL257195A patent/IL257195A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018528948A5 (enExample) | ||
| WO2016065209A3 (en) | Process for the preparation of (r,s)-nicotine | |
| JP2014512451A5 (enExample) | ||
| JP2014534287A5 (enExample) | ||
| JP2008235603A5 (enExample) | ||
| JP2016535744A5 (enExample) | ||
| JP2018507858A5 (enExample) | ||
| JP2012001634A5 (enExample) | ||
| JP2018509457A5 (enExample) | ||
| JP2017520547A5 (enExample) | ||
| JP2015532666A5 (enExample) | ||
| JP2017523196A5 (enExample) | ||
| RU2011154176A (ru) | Способ получения 6-(арил)-4-аминопиколинатов | |
| JP2015512868A5 (ja) | ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化 | |
| RU2017133243A (ru) | Частицы n-(5-циано-4-((2-метоксиэтил)амино)пиридин-2-ил)-7-формил-6-((4-метил-2-оксопиперазин-1-ил)метил)-3,4-дигидро-1,8-нафтиридин-1(2h)-карбоксамида | |
| JP2016000763A5 (enExample) | ||
| JP2011527330A5 (enExample) | ||
| JP2015183178A5 (enExample) | ||
| JP2015518469A5 (enExample) | ||
| JP2018009003A5 (enExample) | ||
| JP2018534942A5 (enExample) | ||
| JP2010205731A5 (enExample) | ||
| JP2017533926A5 (enExample) | ||
| JP2017517513A5 (enExample) | ||
| JP2016520122A5 (enExample) |